The revised ADA guidelines state that 2 large clinical trials justify consideration of empagliflozin or liraglutide in patients with established cardiovascular disease to reduce the risk of death. ADA ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. A growing number of diabetes technology companies are ...

The 2019 Standards of Care reflect an ongoing collaboration between the American Diabetes Association and the American College of Cardiology. The growing connection between treatment for diabetes and ...

The American Diabetes Association and Abbott recently announced a collaboration to better understand the nutritional needs of people living with diabetes, obesity and metabolic dysfunction. The ...

It’s another high-profile partnership for IBM Watson Health. Sunday at the American Diabetes Association’s 76th annual Scientific Sessions meeting in New Orleans, IBM announced that it was teaming up ...

The coronavirus disease 2019 (COVID-19) pandemic will hopefully be a wakeup call to take diabetes more seriously and to work to prevent diabetes and its complications, said Robert Gabbay, MD, PhD, ...

The American Diabetes Association's annual guidelines for 2018 include new recommendations for use of glucose-lowering drugs with proven cardiovascular benefit in type 2 diabetes, optimization of ...

Based on international clinical trials (ACCORD, ADVANCE, VADT and UKPDS), the ADA recommends a reasonable A1C goal for adults with type 2 diabetes of ≤7%. The American Diabetes Association has ...

The American Diabetes Association (ADA) released its first position statement that includes detailed guidelines for psychosocial assessments and care based on factors including age, type of diabetes, ...

For the first time in its annual diabetes management guidelines, the American Diabetes Association (ADA) has aligned its recommendations with those of the American College of Cardiology (ACC) for ...

In early 2020, upon recommendation by leading endocrinologists, American Diabetes Association lowered the target hemoglobin A1C guidelines for children with type 1 diabetes. Their goal in recommending ...